NasdaqCM - Nasdaq Real Time Price ? USD Shineco, Inc. (SISI) Follow Compare 2.7700 +0.1600 (+6.13%) At close: 4:00 PM EST 2.6400 -0.13 (-4.69%) After hours: 5:13 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Shineco Announces Reverse Split to Regain NASDAQ Compliance BEIJING, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer of innovative diagnostic medical products and related medical devices, announced today that effective at 12:01 a.m., EDT, on November 12, 2024, the Company will effect a one-for-twenty four (1-for-24) reverse stock split of its outstanding common stock (the “Reverse Stock Split”). The Reverse Stock Split is primarily intended to bring the Company into compliance with the minimum average GlobeNewswire ? 10 days ago SISI +6.13% Shineco Approves Key Proposals at 2025 AGM Shineco ( (SISI) ) just unveiled an announcement. The Company recently held its 2025 annual general meeting, where key proposals were approved, including a reverse stock split, the 2025 Equity Incentive Plan, the election of seven directors, and the reappointment of Assentsure PAC as the accounting firm. These decisions, reflecting significant shareholder support, aim to enhance the company’s financial structure and governance. For a thorough assessment of SISI stock, go to TipRanks’ Stock Analy TipRanks ? 27 days ago SISI +6.13% Shineco Announces Closing of $2 Million Underwritten Public Offering Beijing, July 15, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced the closing of its underwritten public offering of 1,869,160 shares of its common stock at a public offering price of $1.07 per share of common stock, for aggregate gross proceeds of approximately $2 million, prior to deducting underwriting discounts and other offering expenses. In addition, the Com GlobeNewswire ? 4 months ago SISI +6.13% Shineco Announces Pricing of $2 Million Underwritten Public Offering Beijing, July 12, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced the pricing of its underwritten public offering of 1,869,160 shares of its common stock at a public offering price of $1.07 per share of common stock, for aggregate gross proceeds of approximately $2 million, prior to deducting underwriting discounts and other offering expenses. In addition, the Com GlobeNewswire ? 4 months ago SISI +6.13% Shineco Announces Proposed Underwritten Public Offering Beijing, July 11, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced it has commenced an underwritten public offering of shares of its common stock and pre-funded warrants to purchase its shares of common stock. All of the shares of common stock and pre-funded warrants and the shares of common stock underlying the pre-funded warrants are being offered by the Company. GlobeNewswire ? 4 months ago SISI +6.13% Shineco Announces New Distribution Agreements for over $30 Million in Sales for its New Health Food Beverage The Company believes that its Advanced Proprietary Production Technology Provides it with a Competitive Advantage in the Sector BEIJING, July 10, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, announced today that its subsidiary, Fuzhou Meida Health Management Co., Ltd. (“Fuzhou Meida”), has entered into Distribution Agreements (the “Agreements”) for its water-soluble phospholipi GlobeNewswire ? 4 months ago SISI +6.13% Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement BEIJING, June 27, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer of innovative diagnostic medical products and related medical devices, announced today that on June 5, 2024, the Company received a formal notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). The notice indicated t GlobeNewswire ? 4 months ago SISI +6.13% Shineco, Inc. Announces Entering into a Securities Purchase Agreement with Gross Proceeds of $7.0 Million BEIJING, June 24, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, announced today that on June 20, 2024, the Company entered into a Securities Purchase Agreement (the “SPA”) with certain non-U.S. investors (each individually, a “Purchaser,” and collectively, the “Purchasers”). Pursuant to the SPA, the Company will issue up to 1,400,000 shares of its common stock (the “Shares”) to GlobeNewswire ? 4 months ago SISI +6.13% Shineco Enters into a Letter of Intent with Meitong Technology to Address China’s Aging Population BEIJING, June 20, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (“Shineco” or the “Company”; NASDA: SISI), a producer of innovative diagnostic medical products and related medical devices announced today that on June 18, 2024, it entered into an Investment Letter of Intent (the “Investment LOI”) with Beijing Oriental Meitong Technology Co., Ltd. (“Meitong Technology”) whereby Shineco intends to invest $20 million in Meitong Technology in exchange for 80% of Meitong Technology’s shares. The Company belie GlobeNewswire ? 5 months ago SISI +6.13% Shineco Enters into an Agreement with Turing Video to Jointly Develop Intelligent Health Care Products Beijing, June 17, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer of innovative diagnostic medical products and related medical devices announced today that on June 14, 2024, its 51% owned subsidiary, Shangkang Life Science and Technology (Jiangsu) Co., Ltd. (“Shangkang Life Science”) entered into a Strategic Cooperation Framework Agreement (“the Agreement”) with Turing Video (Shenzhen) Co., Ltd (“Turing Video”) to jointly develop a series of smart me GlobeNewswire ? 5 months ago SISI +6.13% Shineco Develops Revolutionary New Product with Varied Applications to Positively Impact the Health Care Industry Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today that its subsidiaries Fuzhou Medashan Biotechnology Co., Ltd. and Kaifeng Yixi Biotechnology Co., Ltd. have innovatively invented a new natural active water-soluble product extracted from soybean gum. Pure physical extraction technology of natural active phospholipids - Large column chromatography polar ultrafiltration membrane pure physical extractio PR Newswire ? 6 months ago SISI +6.13% Shineco Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement BEIJING, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today that the Company’s Board of Directors has approved a reverse stock split of its issued and outstanding shares of common stock, par value $0.001 per share (the “Common Stock”), at a ratio of 1-for-10. The Company is effecting the reverse split to regain compliance with the $1.00 minimum bid price required for GlobeNewswire ? 9 months ago SISI +6.13% Performance Overview Trailing total returns as of 11/22/2024, which may include dividends or other distributions. Benchmark is S&P 500 Return SISI S&P 500 YTD -89.79% +25.15% 1-Year -89.21% +31.54% 3-Year -99.88% +27.06%
